女性支气管哮喘的独特因素：绝经?性激素治疗?

doi:10.12280/gjfckx.20220416

摘要/Abstract

摘要：

支气管哮喘是一种常见的呼吸系统疾病,表现为反复发作的喘息、气急和胸闷等,发病急骤,病情多变,严重时危及生命,给个人和社会带来沉重的负担。女性支气管哮喘的独立影响因素包括过敏原、遗传和环境等,研究表明绝经及性激素治疗也可能是其重要的影响因素。目前国内关于绝经及性激素治疗与支气管哮喘的研究较少,临床医师对此认知不足,容易给围绝经期女性的支气管哮喘的预防和治疗造成困扰。通过总结国内外最新研究,综述绝经、性激素治疗对支气管哮喘发生的影响及作用机制,以期为临床医师提供诊疗指导,为围绝经期女性提供更好的三级预防服务。

关键词: 绝经期, 围绝经期, 雌激素替代疗法, 哮喘, 孕激素类

Abstract:

Bronchial asthma is a common respiratory disease, manifested as recurrent wheezing, shortness of breath, chest tightness and so on. Bronchial asthma attacks are sudden and changeable, and can be life-threatening in severe cases. It brings heavy burden to personal life and social economy. Studies have shown that female bronchial asthma is not only affected by allergens, genetics, environment and other factors, but also menopause and hormone therapy. However, there are few studies on the relationship between menopause, hormone therapy and bronchial asthma in China. The clinician′s insufficient cognition of the relationship between the two has brought great difficulties to the diagnosis and treatment of bronchial asthma in postmenopausal women. This article is to summarize the latest researches at home and abroad, and to review the effect and mechanism of menopause and sex hormone therapy on asthma, with a view to providing guidance for clinicians in diagnosis and treatment, provide better tertiary prevention services for perimenopausal women.

Key words: Menopause, Perimenopause, Estrogen replacement therapy, Asthma, Progestins

王小雪, 杨慕坤, 白文佩. 女性支气管哮喘的独特因素：绝经?性激素治疗?[J]. 国际妇产科学杂志, 2022, 49(4): 456-460.

WANG Xiao-xue, YANG Mu-kun, BAI Wen-pei. Unique Factors in Female Bronchial Asthma: Menopause? Hormone Therapy?[J]. Journal of International Obstetrics and Gynecology, 2022, 49(4): 456-460.

参考文献 37

[1]	中国老年医学学会呼吸病学分会哮喘学术工作委员会. 老年人支气管哮喘诊断与管理中国专家共识[J]. 中华医学杂志, 2020, 100(38):2970-2981. doi: 10.3760/cma.j.cn112137-2020723-02200. doi: 10.3760/cma.j.cn112137-2020723-02200
[2]	钟南山. 我国支气管哮喘防治研究重点及努力方向[J]. 中华结核和呼吸杂志, 2005, 28(12):809-811. doi: 10.3760/j:issn:1001-0939. 2005.12.001. doi: 10.3760/j:issn:1001-0939. 2005.12.001
[3]	Ridolo E, Incorvaia C, Martignago I, et al. Sex in Respiratory and Skin Allergies[J]. Clin Rev Allergy Immunol, 2019, 56(3):322-332. doi: 10.1007/s12016-017-8661-0. doi: 10.1007/s12016-017-8661-0
[4]	Calcaterra V, Nappi RE, Farolfi A, et al. Perimenstrual Asthma in Adolescents: A Shared Condition in Pediatric and Gynecological Endocrinology[J]. Children(Basel), 2022, 9(2):233. doi: 10.3390/children9020233. doi: 10.3390/children9020233
[5]	Raherison C, Hamzaoui A, Nocent-Ejnaini C, et al. Woman′s asthma throughout life: Towards a personalized management?[J]. Rev Mal Respir, 2020, 37(2):144-160. doi: 10.1016/j.rmr.2019.07.013. doi: S0761-8425(20)30013-9 pmid: 32057504
[6]	Kisiel MA, Berglund C, Janson C, et al. Quality of life and asthma control related to hormonal transitions in women′s lives[J]. J Asthma, 2021 Aug 28:1-9. doi: 10.1080/02770903.2021.1963768. doi: 10.1080/02770903.2021.1963768
[7]	Real FG, Svanes C, Omenaas ER, et al. Lung function, respiratory symptoms, and the menopausal transition[J]. J Allergy Clin Immunol, 2008, 121(1):72-80.e3. doi: 10.1016/j.jaci.2007.08.057. doi: 10.1016/j.jaci.2007.08.057
[8]	Triebner K, Johannessen A, Puggini L, et al. Menopause as a predictor of new-onset asthma: A longitudinal Northern European population study[J]. J Allergy Clin Immunol, 2016, 137(1):50-57.e6. doi: 10.1016/j.jaci.2015.08.019. doi: S0091-6749(15)01243-9 pmid: 26435006
[9]	Troisi RJ, Speizer FE, Willett WC, et al. Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. A prospective cohort study[J]. Am J Respir Crit Care Med, 1995, 152(4 Pt 1):1183-1188. doi: 10.1164/ajrccm.152.4.7551368. doi: 10.1164/ajrccm.152.4.7551368
[10]	Patel J, Gimeno Ruiz de Porras D, Mitchell LE, et al. Work-Related Asthma Among Certified Nurse Aides in Texas[J]. Workplace Health Saf, 2020, 68(10):491-500. doi: 10.1177/2165079920914322. doi: 10.1177/2165079920914322
[11]	Matulonga-Diakiese B, Courbon D, Fournier A, et al. Risk of asthma onset after natural and surgical menopause: Results from the French E3N cohort[J]. Maturitas, 2018, 118:44-50. doi: 10.1016/j.maturitas.2018.10.006. doi: S0378-5122(18)30325-6 pmid: 30415754
[12]	Jarvis D, Leynaert B. The association of asthma, atopy and lung function with hormone replacement therapy and surgical cessation of menstruation in a population-based sample of English women[J]. Allergy, 2008, 63(1):95-102. doi: 10.1111/j.1398-9995.2007.01530.x. doi: 10.1111/j.1398-9995.2007.01530.x pmid: 17970824
[13]	Wasti B, Chen Z, He Y, et al. Role of Sex Hormones at Different Physiobiological Conditions and Therapeutic Potential in MBD2 Mediated Severe Asthma[J]. Oxid Med Cell Longev, 2021, 2021:7097797. doi: 10.1155/2021/7097797. doi: 10.1155/2021/7097797
[14]	Gómez Real F, Svanes C, Björnsson EH, et al. Hormone replacement therapy, body mass index and asthma in perimenopausal women: a cross sectional survey[J]. Thorax, 2006, 61(1):34-40. doi: 10.1136/thx.2005.040881. doi: 10.1136/thx.2005.040881 pmid: 16244093
[15]	Lieberman D, Kopernik G, Porath A, et al. Sub-clinical worsening of bronchial asthma during estrogen replacement therapy in asthmatic post-menopausal women[J]. Maturitas, 1995, 21(2):153-157. doi: 10.1016/0378-5122(94)00890-j. doi: 10.1016/0378-5122(94)00890-j pmid: 7752953
[16]	Nwaru BI, Shah SA, Tibble H, et al. Hormone Replacement Therapy and Risk of Severe Asthma Exacerbation in Perimenopausal and Postmenopausal Women: 17-Year National Cohort Study[J]. J Allergy Clin Immunol Pract, 2021, 9(7):2751-2760.e1. doi: 10.1016/j.jaip.2021.02.052. doi: 10.1016/j.jaip.2021.02.052
[17]	Zhang GQ, Chen JL, Luo Y, et al. Menopausal hormone therapy and women′s health: An umbrella review[J]. PLoS Med, 2021, 18(8):e1003731. doi: 10.1371/journal.pmed.1003731. doi: 10.1371/journal.pmed.1003731
[18]	Romieu I, Fabre A, Fournier A, et al. Postmenopausal hormone therapy and asthma onset in the E3N cohort[J]. Thorax, 2010, 65(4):292-297. doi: 10.1136/thx.2009.116079. doi: 10.1136/thx.2009.116079
[19]	Nejatbakhsh Samimi L, Fallahpour M, Khoshmirsafa M, et al. The impact of 17β-estradiol and progesterone therapy on peripheral blood mononuclear cells of asthmatic patients[J]. Mol Biol Rep, 2021, 48(1):297-306. doi: 10.1007/s11033-020-06046-6. doi: 10.1007/s11033-020-06046-6 pmid: 33315175
[20]	Hansen E, Aasbjerg K, Moeller AL, et al. Hormone Replacement Therapy and Development of New Asthma[J]. Chest, 2021, 160(1):45-52. doi: 10.1016/j.chest.2021.01.054. doi: 10.1016/j.chest.2021.01.054
[21]	Shah SA, Tibble H, Pillinger R, et al. Hormone replacement therapy and asthma onset in menopausal women: National cohort study[J]. J Allergy Clin Immunol, 2021, 147(5):1662-1670. doi: 10.1016/j.jaci.2020.11.024. doi: 10.1016/j.jaci.2020.11.024
[22]	Tidemandsen C, Halvard Hansen ES, Rasmussen SM, et al. Unique Aspects of Asthma in Women[J]. Clin Chest Med, 2021, 42(3):497-506. doi: 10.1016/j.ccm.2021.04.009. doi: 10.1016/j.ccm.2021.04.009 pmid: 34353454
[23]	Han YY, Forno E, Celedón JC. Sex Steroid Hormones and Asthma in a Nationwide Study of U.S. Adults[J]. Am J Respir Crit Care Med, 2020, 201(2):158-166. doi: 10.1164/rccm.201905-0996OC. doi: 10.1164/rccm.201905-0996OC
[24]	Corren J, Pham TH, Garcia Gil E, et al. Baseline type 2 biomarker levels and response to. tezepelumab in severe asthma[J]. Allergy, 2022, 77(6):1786-1796. doi: 10.1111/all.15197. doi: 10.1111/all.15197
[25]	Hammad H, Lambrecht BN. The basic immunology of asthma[J]. Cell, 2021, 184(6):1469-1485. doi: 10.1016/j.cell.2021.02.016. doi: 10.1016/j.cell.2021.02.016
[26]	Takeda M, Tanabe M, Ito W, et al. Gender difference in allergic airway remodelling and immunoglobulin production in mouse model of asthma[J]. Respirology, 2013, 18(5):797-806. doi: 10.1111/resp.12078. doi: 10.1111/resp.12078
[27]	Blacquière MJ, Hylkema MN, Postma DS, et al. Airway inflammation and remodeling in two mouse models of asthma: comparison of males and females[J]. Int Arch Allergy Immunol, 2010, 153(2):173-181. doi: 10.1159/000312635. doi: 10.1159/000312635
[28]	Riffo-Vasquez Y, Ligeiro de Oliveira AP, Page CP, et al. Role of sex hormones in allergic inflammation in mice[J]. Clin Exp Allergy, 2007, 37(3):459-470. doi: 10.1111/j.1365-2222.2007.02670.x. doi: 10.1111/j.1365-2222.2007.02670.x pmid: 17359396
[29]	Ambhore NS, Kalidhindi R, Loganathan J, et al. Role of Differential Estrogen Receptor Activation in Airway Hyperreactivity and Remodeling in a Murine Model of Asthma[J]. Am J Respir Cell Mol Biol, 2019, 61(4):469-480. doi: 10.1165/rcmb.2018-0321OC. doi: 10.1165/rcmb.2018-0321OC
[30]	Watanabe Y, Tajiki-Nishino R, Tajima H, et al. Role of estrogen receptors α and β in the development of allergic airway inflammation in mice: A possible involvement of interleukin 33 and eosinophils[J]. Toxicology, 2019, 411:93-100. doi: 10.1016/j.tox.2018.11.002. doi: S0300-483X(18)30331-7 pmid: 30445053
[31]	Jamieson PM, Nyirenda MJ, Walker BR, et al. Interactions between oestradiol and glucocorticoid regulatory effects on liver-specific glucocorticoid-inducible genes: possible evidence for a role of hepatic 11beta-hydroxysteroid dehydrogenase type 1[J]. J Endocrinol, 1999, 160(1):103-109. doi: 10.1677/joe.0.1600103. doi: 10.1677/joe.0.1600103 pmid: 9854182
[32]	Muñoz-Cruz S, Mendoza-Rodríguez Y, Nava-Castro KE, et al. Gender-related effects of sex steroids on histamine release and FcεRI expression in rat peritoneal mast cells[J]. J Immunol Res, 2015, 2015:351829. doi: 10.1155/2015/351829. doi: 10.1155/2015/351829
[33]	Bengtsson AK, Ryan EJ, Giordano D, et al. 17beta-estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells[J]. Blood, 2004, 104(5):1404-1410. doi: 10.1182/blood-2003-10-3380. doi: 10.1182/blood-2003-10-3380 pmid: 15142882
[34]	Paharkova-Vatchkova V, Maldonado R, Kovats S. Estrogen preferentially promotes the differentiation of CD11c+ CD11b(intermediate) dendritic cells from bone marrow precursors[J]. J Immunol, 2004, 172(3):1426-1436. doi: 10.4049/jimmunol.172.3.1426. doi: 10.4049/jimmunol.172.3.1426 pmid: 14734718
[35]	Paplinska-Goryca M, Misiukiewicz-Stepien P, Proboszcz M, et al. The Expressions of TSLP, IL-33, and IL-17A in Monocyte Derived Dendritic Cells from Asthma and COPD Patients are Related to Epithelial-Macrophage Interactions[J]. Cells, 2020, 9(9):1944. doi: 10.3390/cells9091944. doi: 10.3390/cells9091944
[36]	Tan R, Liew MF, Lim HF, et al. Promises and challenges of biologics for severe asthma[J]. Biochem Pharmacol, 2020, 179:114012. doi: 10.1016/j.bcp.2020.114012. doi: 10.1016/j.bcp.2020.114012
[37]	Newcomb DC, Cephus JY, Boswell MG, et al. Estrogen and progesterone decrease let-7f microRNA expression and increase IL-23/IL-23 receptor signaling and IL-17A production in patients with severe asthma[J]. J Allergy Clin Immunol, 2015, 136(4):1025-1034.e11. doi: 10.1016/j.jaci.2015.05.046. doi: 10.1016/j.jaci.2015.05.046 pmid: 26242299